Home Cart Sign in  
Chemical Structure| 441785-25-7 Chemical Structure| 441785-25-7

Structure of Besifovir
CAS No.: 441785-25-7

Chemical Structure| 441785-25-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Besifovir is an orally active anti-HBV drug with significant antiviral activity, used for the treatment of hepatitis B.

Synonyms: LB80331

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Besifovir

CAS No. :441785-25-7
Formula : C10H14N5O4P
M.W : 299.22
SMILES Code : NC1=NC=C2N=CN(CC3(OCP(O)(O)=O)CC3)C2=N1
Synonyms :
LB80331
MDL No. :MFCD09834071
InChI Key :KDNSSKPZBDNJDF-UHFFFAOYSA-N
Pubchem ID :5270766

Safety of Besifovir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Besifovir (LB80331), transformed from LB80380, undergoes further metabolic conversion to its active derivative, LB80317. It is identified as an innovative, orally administered antiviral compound effective against the hepatitis B virus (HBV)[1].[2].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.34mL

0.67mL

0.33mL

16.71mL

3.34mL

1.67mL

33.42mL

6.68mL

3.34mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories